Oncology News & Articles

181 High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients Full Text BMC Cancer, June 18, 2013

182 Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma Tumor Biology, June 18, 2013

183 Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancer Cancer Epidemiology, June 18, 2013

184 Molecular subtypes of ductal carcinoma in situ in African American and Caucasian American Women: Distribution and correlation with pathological features and outcome Cancer Epidemiology, June 18, 2013

185 Effects of polymorphisms in alcohol metabolism and oxidative stress genes on survival from head and neck cancer Cancer Epidemiology, June 18, 2013

186 Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme Cancer Epidemiology, June 18, 2013

187 A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer International Journal of Clinical Oncology, June 18, 2013

188 Meat-Related Mutagens and Pancreatic Cancer: Null Results from a Clinic-Based Case–Control Study Cancer Epidemiology, Biomarkers & Prevention, June 18, 2013    Clinical Article

189 Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy Full Text Evidence-based Complementary and Alternative Medicine , June 18, 2013    Review Article

190 Physical Activity and Risk of Lymphoma: A Meta-Analysis Cancer Epidemiology, Biomarkers & Prevention, June 18, 2013    Evidence Based Medicine    Clinical Article

191 Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study Journal of Clinical Gastroenterology, June 18, 2013    Clinical Article

192 Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study Cancer Chemotherapy and Pharmacology, June 18, 2013    Clinical Article

193 A notch3 transcriptional module induces cell motility in neuroblastoma Clinical Cancer Research, June 18, 2013    Clinical Article

194 High prevalence of brca1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions Clinical Cancer Research, June 18, 2013    Clinical Article

195 Use of multiple endpoints and approval paths depicts a decade of fda oncology drug approvals Clinical Cancer Research, June 18, 2013    Review Article

196 Subsequent brain tumors in patients with autoimmune disease Neuro-Oncology, June 18, 2013    Clinical Article

197 Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming Cancer Cell, June 18, 2013    Clinical Article

198 Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: Focus on epidermal growth factor receptor mutation testing and mutation-positive patients Cancer Treatment Reviews, June 18, 2013    Clinical Article

199 A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome and miRNome analysis Clinical Cancer Research, June 18, 2013    Clinical Article

200 Screening metatranscriptomes for toxin genes as functional drivers of human colorectal cancer Best Practice & Research Clinical Gastroenterology , June 18, 2013    Review Article

1 Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202) Journal of Clinical Oncology, April 15, 2013

2 Neoadjuvant chemotherapy with or without zoledronic acid in early breast cancer: a randomized biomarker pilot study Clinical Cancer Research, May 6, 2013

3 Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer Journal of the National Cancer Institute, May 1, 2013

4 Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma Annals of Oncology, May 6, 2013

5 Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles The Lancet, April 23, 2013

6 Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial The Lancet Oncology, May 17, 2013

7 Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial The Lancet Oncology, May 3, 2013

8 Association of metformin use with cancer incidence and mortality: A meta-analysis Cancer Epidemiology, April 22, 2013    Review Article

9 Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial European Journal of Cancer, April 2, 2013

10 Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial The Lancet Oncology, May 3, 2013

11 Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: Patterns of failure and prognostic factors Cancer, April 12, 2013

12 Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: Results from the HERA Trial Journal of Clinical Oncology, April 25, 2013

13 Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study The Lancet Oncology, May 3, 2013

14 AVEREL: A randomized phase III trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer Journal of Clinical Oncology, April 15, 2013

15 Survival of pediatric patients after relapsed osteosarcoma: The St. Jude Childrens Research Hospital experience Cancer, May 2, 2013

16 Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An International Tamoxifen Exemestane Adjuvant Multinational Trial analysis Journal of Clinical Oncology, April 30, 2013

17 Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer British Journal of Cancer, May 7, 2013

18 Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis Journal of the National Cancer Institute, April 19, 2013    Evidence Based Medicine

19 Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study Journal of Clinical Oncology, April 29, 2013

20 Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial The Lancet Oncology, April 23, 2013